Michael J. Raphael
Impact in
Papers in
- Oncology 28
- Pancreatic and Hepatic Oncology Research 10
- Colorectal Cancer Treatments and Studies 7
- Colorectal Cancer Surgical Treatments 6
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Christopher M. BoothJames BiagiWilliam J. MackillopWeidong KongWill D. KingMelanie JaegerJanet van VlymenMihaela Mates
- Journals
- Journal of Clinical Oncology (9 papers)Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (3 papers)Annals of Oncology (2 papers)JAMA Oncology (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Michael J. Raphael
50 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 609
- Surgery 479
- Cancer Research 115
- Pulmonary and Respiratory Medicine 219
- Otorhinolaryngology 27
Countries citing papers authored by Michael J. Raphael
This map shows the geographic impact of Michael J. Raphael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Raphael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Raphael more than expected).
Fields of papers citing papers by Michael J. Raphael
This network shows the impact of papers produced by Michael J. Raphael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Raphael. The network helps show where Michael J. Raphael may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael J. Raphael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 12 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 18 | |
| 14 | 2018 | 23 | |
| 15 | 2018 | 14 | |
| 16 | 2016 | 102 | |
| 17 | Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer Hit paper breakdown → | 2011 | 463 |
| 18 | Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study | 2007 | 1 |
| 19 | Deletion of cranial irradiation and addition of systemic high dose methotrexate and intrathecal chemotherapy results in 70% 4-yr. EFS in children and adolescents with CNS positive B-NHL: Results of International FAB/LMB 96 study | 2005 | 6 |
| 20 | Poor response to initial reduction therapy (COP) and combined bone marrow and CNS disease are poor prognostic factors in children with advanced (BM +/- CNS) B-NHL treated on the international study FAB/LMB96. | 2003 | 1 |
About Michael J. Raphael
Michael J. Raphael is a scholar working on Oncology, Cancer Research, Internal Medicine, Hepatology and Surgery, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Economic and Financial Impacts of Cancer (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Colorectal Cancer Surgical Treatments (6 papers), Cancer Genomics and Diagnostics (6 papers), Testicular diseases and treatments (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Oncology (609 citations), Surgery (479 citations), Cancer Research (115 citations), Pulmonary and Respiratory Medicine (219 citations) and Otorhinolaryngology (27 citations). Michael J. Raphael has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Christopher M. Booth, James Biagi, William J. Mackillop, Weidong Kong, Will D. King, Melanie Jaeger, Janet van Vlymen, Christopher M. Booth, Mihaela Mates and Paul J. Karanicolas. Their work appears in journals such as Journal of Clinical Oncology, Clinical Oncology, JNCI Journal of the National Cancer Institute, Annals of Oncology and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.